News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

MBK Partners Sells Luye Pharma Group Ltd. Stake to Fellow PE Funds


3/5/2012 8:59:08 AM

March 2, 2012 -- In an unusual move, one private equity fund has sold its majority ownership in a China pharma to three other funds, a rare fund-to-fund transaction. MBK Partners, a PE group based in Korea, sold its 77% interest in Luye Pharma Group, a Singapore listed company that operates mainly in China. According to the Wall Street Journal, the transaction shows that investor funds have more investable capital than attractive targets, while public valuations are low by comparison. The selling price has not been disclosed. More details.....

Read at ChinaBio Today

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES